We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Light-Induced Immunoassay Selectively Detects Coronavirus Spike Proteins In 5 Minutes

By LabMedica International staff writers
Posted on 19 Sep 2024

Like moths drawn to a flame, microbes can also be influenced by light. Using this principle, researchers have developed a method to quickly detect viruses using only a small sample.

Scientists at Osaka Metropolitan University's Research Institute for Light-induced Acceleration System (RILACS) have developed a light-induced immunoassay for virus detection. By applying laser irradiation for less than a minute, they used a nanoparticle-imprinted plasmonic substrate with nanobowl structures (each 500 nm in diameter) coated with antibodies for the spike proteins of the novel coronavirus. A low-power 5-milliwatt laser, similar to commercial laser pointers, was able to form bubbles on the biochip that attracted virus-mimicking nanoparticles, speeding up the selective detection of these particles.


Image: Using a light-induced immunoassay to detect viruses (Photo courtesy of Osaka Metropolitan University)
Image: Using a light-induced immunoassay to detect viruses (Photo courtesy of Osaka Metropolitan University)

The process works because light-induced convection causes the nanoparticles to move and gather at a stagnant region between the substrate surface and the bottom of the bubble, meaning a high particle concentration isn't necessary. The entire procedure—from coating the substrate to detecting the virus—can be completed in under 5 minutes, as reported in the journal npj Biosensing.

“This study shows that we can shorten the cumbersome antibody coating process and perform rapid and highly sensitive protein detection,” said OMU Professor Takuya Iida, the director of RILACS. “We believe our findings can contribute to the early diagnosis of not only the novel coronavirus, but possibly also various infectious diseases, cancer, even dementia.”

Related Links:
RILACS


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Gold Member
Troponin T QC
Troponin T Quality Control
New
Electroporation System
Gibco CTS Xenon
New
Adenovirus Test
S3334E ADV Adenovirus Kit

Latest Molecular Diagnostics News

Blood Test for Early Alzheimer’s Detection Could Help Slow Disease Progression

Cost-Effective Blood Test Could Detect Early Brain Changes Leading to Dementia

New Test for Early Osteoarthritis Diagnosis to Improve Clinical Decision-Making